More than 90% of mastocytosis cases are characterized by a somatic point mutation of KIT, the majority of which induces ligand-independent activation of the receptor and downstream signal activation, ultimately leading to mast cell proliferation and survival [42,43]. This evidence concerns the gene KIT and mastocytosis.